Neutropénie et rituximab : Effets secondaires émergents des traitements en hématologie = Late onset neutropeniaTCHERNONOG, E; CARTRON, G.Correspondances en onco-hématologie. 2014, Vol 9, Num 4-5, pp 164-168, issn 1954-4820, 5 p.Article

Rituximab: quelle dose et combien de cycles dans les lymphomes agressifs ? = Rituximab: which measures and how many cycles in diffuse large B-cell lymphomas?BOUHYA, S; CARTRON, G.Correspondances en onco-hématologie. 2009, Vol 4, Num 4, pp 151-155, issn 1954-4820, 5 p.Article

Trends in G-CSF use in 990 patients after EORTC and ASCO guidelinesFALANDRY, C; CAMPONE, M; CARTRON, G et al.European journal of cancer (1990). 2010, Vol 46, Num 13, pp 2389-2398, issn 0959-8049, 10 p.Article

Leucémies aiguës lymphoblastiques de l'enfant : Facteurs pronostiques et traitements actuels = Lymphoblastic leukaemia in children : predictive factors and treatmentsCARTRON, G; LEJARS, O; LAMAGNERE, J.-P et al.Revue de Médecine de Tours. 1997, Vol 31, Num 5, pp 251-258, issn 0557-7721Article

Neutrophil role in in vivo anti-lymphoma activity of rituximab : FCGP3B-NA1/NA2 polymorphism does not influence response and survival after rituximab treatmentCARTRON, G; OHRESSER, M; SALLES, G et al.Annals of oncology. 2008, Vol 19, Num 8, pp 1485-1487, issn 0923-7534, 3 p.Article

Proliferation of human progenitor cells in a long-term culture system is more efficiently sustained by the addition of Flt-3 ligand or megakaryocyte growth and development factor than by kit ligandCARTRON, G; BINET, C; HERAULT, O et al.International journal of hematology. 2003, Vol 77, Num 2, pp 133-141, issn 0925-5710, 9 p.Article

A new serologic index for low-grade non-Hodgkin's lymphoma based on initial CA125 and LDH serum levelsBENBOUBKER, L; VALAT, C; LINASSIER, C et al.Annals of oncology. 2000, Vol 11, Num 11, pp 1485-1491, issn 0923-7534Article

Transfusion thérapeutique de granulocytes: cinétique et aspects organisationnels autour d'un cas clinique = Kinetic and organization of granulocytes transfusion: A case reportLAMURE, S; LATRY, P; KANOUNI, T et al.Transfusion clinique et biologique (Paris). 2014, Vol 21, Num 6, pp 324-327, issn 1246-7820, 4 p.Article

Follicular lymphoma prognostic factors in the modern era: what is clinically meaningful?SOLAL-CELIGNY, Ph; CAHU, X; CARTRON, G et al.International journal of hematology. 2010, Vol 92, Num 2, pp 246-254, issn 0925-5710, 9 p.Article

Comment traiter un cancer du sein évolué ? L'intérêt de la reconstruction mammaire par épiploplastie avec prélèvement coelioscopiqueCARTRON, G; FERRON, G; GARRIDO, I et al.La Lettre du sénologue. 2004, Num 23, pp 18-19, issn 1289-2505, 2 p.Article

Early secondary acute myelogenous leukemia in breast cancer patients after treatment with mitoxantrone, cyclophosphamide, fluorouracil and radiation therapyLINASSIER, C; BARIN, C; BENBOUBKER, L et al.Annals of oncology. 2000, Vol 11, Num 10, pp 1289-1294, issn 0923-7534Article

Rôle des récepteurs à la portion Fc des IgG (FcγRs) dans l'activité des anticorps thérapeutiques = Implications of receptors for the Fc portion of IgG (FcγRs) in mechanism of action of therapeutic antibodiesLEJEUNE, J; THIBAULT, G; CARTRON, G et al.Bulletin du cancer. 2010, Vol 97, Num 5, pp 511-522, issn 0007-4551, 12 p.Article

A phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory mantle cell lymphomaMORSCHHAUSER, F; SEYMOUR, J. F; CARTRON, G et al.Annals of oncology. 2008, Vol 19, Num 2, pp 247-253, issn 0923-7534, 7 p.Article

Evaluation of a peptide ELISA for the detection of rituximab in serumBLASCO, H; LALMANACH, G; LE GUELLEC, C et al.Journal of immunological methods. 2007, Vol 325, Num 1-2, pp 127-139, issn 0022-1759, 13 p.Article

Complications des lymphadénectomies coelioscopiques en oncologie gynécologique : 1102 interventions chez 915 patientes = Complications of laparoscopic lymphadenectomy in gynecologic oncology. A series of 1102 procedures in 915 patientsCARTRON, G; LEBLANC, E; FERRON, G et al.La Lettre du gynécologue. 2005, Num 303, pp 32-41, issn 0759-1594, 9 p.Article

Visceral leishmaniasis. Persistence of parasites in lymph nodes after clinical cureDEREURE, J; DUONG THANH, H; LAVABRE-BERTRAND, T et al.The Journal of infection. 2003, Vol 47, Num 1, pp 77-81, issn 0163-4453, 5 p.Article